stockrow
Friday 6 November 2026
Export BWIN’s income statement to Excel — free account
Baldwin Insurance Group, Inc.
BWIN Financial Insurance Brokers
Baldwin Insurance Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 8.34% from fiscal 2024.
- Revenue
- +30.1%
- EPS
- −740.0%
- Free cash flow
- +208.1%
- Total debt
- +52.7%
Quarter to June 2026, against a year earlier
31.98
0.16
−0.50%
Follow BWIN
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 4 | 4 | 6 | 3 | 5 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 272.83 | 272.83 |
P/S ratio |
1.08 | 1.77 | 1.17 | 1.45 | 3.03 | 3.38 | 2.09 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 236.40 | 0.00 | 0.00 | 49.37 | 25.98 | 27.93 | 0.00 | 0.00 |
P/Operating CF |
158.98 | (1,068.89) | (62.53) | 100.07 | 131.30 | 134.71 | (112.55) | 0.00 | 0.00 |
P/B ratio |
1.51 | 2.44 | 1.40 | 1.25 | 1.45 | 1.06 | 1.21 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.00 | 2.59 | 2.10 | 2.60 | 4.27 | 4.39 | 1.87 | 0.00 | 0.00 |
EV/EBITDA |
14.49 | 20.47 | 41.94 | 42.25 | 103.61 | 0.00 | 37.90 | 0.00 | 0.00 |
EV/Operating CF |
(102.17) | 69.80 | 55,601.23 | (1,036.22) | 60.39 | 28.73 | 21.42 | 2.46 | 2.46 |
EV/FCF |
(43.59) | 345.21 | (119.91) | (104.38) | 69.62 | 33.74 | 25.00 | 2.66 | 2.66 |
Quick Ratio |
1.15 | 0.96 | 0.82 | 1.09 | 1.05 | 1.37 | 1.78 | 1.13 | 0.00 |
Current Ratio |
1.16 | 0.97 | 0.90 | 1.10 | 1.07 | 1.39 | 1.83 | 1.16 | — |
Net Debt/EBITDA |
6.39 | 6.19 | 17.84 | 18.73 | 30.14 | (316.46) | (4.52) | 5.09 | 0.00 |
Debt/Assets |
43.32% | 39.55% | 37.38% | 39.33% | 32.42% | 25.19% | 10.12% | 52.04% | 55.56% |
Debt/Equity |
1.54 | 1.39 | 1.29 | 1.19 | 0.79 | 0.50 | 0.17 | (1.16) | (0.62) |
Asset Turnover |
0.41 | 0.39 | 0.35 | 0.31 | 0.26 | 0.25 | 0.51 | 0.86 | 0.52 |
Operating CF/Net income |
0.87 | (2.10) | 0.00 | 0.06 | (1.31) | (2.35) | (1.39) | (18.90) | 4.71 |
Capex/Depreciation |
(0.30) | (0.36) | (0.21) | (0.24) | (0.10) | (0.26) | (0.14) | (0.16) | — |
Interest Coverage |
0.61 | 0.49 | (0.36) | (0.44) | (1.18) | (2.79) | (0.48) | 1.44 | — |
| (3.23%) | (2.42%) | (8.35%) | (3.59%) | (3.13%) | (3.12%) | (9.91%) | 1.21% | (3.28%) | |
| (0.91%) | (0.70%) | (2.59%) | (1.32%) | (1.39%) | (1.63%) | (3.21%) | (0.68%) | 1.84% | |
ROIC |
1.92% | 1.81% | (1.26%) | (0.86%) | (1.04%) | (1.35%) | (1.53%) | 296.15% | 0.00% |
Return on Tangible Assets |
(17.85%) | 307.55% | 106.27% | (42.37%) | (55.54%) | (16.42%) | (13.64%) | (8.30%) | 170.33% |
Average Days of Receivables |
203.54 | 184.49 | 188.05 | 197.99 | 219.30 | 235.59 | 155.68 | 134.27 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.65 | 0.67 | 0.69 | 0.73 | 0.76 | 0.79 | 0.64 | 0.68 | 0.78 |
Share Based Compensation of Revenue |
4.73% | 4.72% | 4.92% | 4.83% | 3.38% | 3.21% | 2.38% | 1.75% | 0.00% |
Graham Net Nets |
(0.97) | (0.61) | (1.09) | (1.09) | (0.65) | (0.56) | (0.10) | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2.00%) | (0.95%) | (6.30%) | (2.84%) | (1.61%) | (1.63%) | (3.24%) | 0.37% | 0.37% |
Free Cash Flow Yield |
(4.22%) | 0.42% | (1.50%) | (1.72%) | 2.03% | 3.85% | 3.58% | 0.00% | 0.00% |
Revenue per Share |
22.15 | 21.89 | 20.26 | 17.26 | 11.92 | 8.87 | 7.69 | 4.24 | 2.55 |
Operating CF per Share |
(0.43) | 0.81 | 0.00 | (0.04) | 0.84 | 1.35 | 0.67 | 0.63 | 0.43 |
Capex per Share |
(0.58) | (0.65) | (0.36) | (0.39) | (0.11) | (0.20) | (0.10) | (0.03) | 0.00 |
Free Cash Flow per Share |
(1.01) | 0.16 | (0.35) | (0.43) | 0.73 | 1.15 | 0.57 | 0.60 | 0.43 |
Cash per Share |
5.11 | 4.93 | 3.68 | 4.06 | 4.79 | 5.23 | 3.97 | 0.42 | 0.16 |
Shareholders Equity per Share |
15.95 | 15.89 | 16.94 | 20.05 | 24.95 | 28.33 | 13.24 | (3.33) | (2.12) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.95 | 15.89 | 16.94 | 20.05 | 24.95 | 28.33 | 13.24 | (3.33) | (2.12) |
Free Cash Flow |
(68.94) | 10.40 | (21.33) | (24.44) | 34.81 | 31.35 | 10.30 | 11.27 | 8.02 |
Working Capital |
166.96 | (29.94) | (107.53) | 73.19 | 37.70 | 84.57 | 60.10 | 5.37 | — |
Capital Expenditures |
(39.53) | (41.05) | (21.38) | (21.98) | (5.32) | (5.47) | (1.72) | (0.52) | (0.43) |
Net Current Asset Value |
(1,578.62) | (1,499.90) | (1,557.54) | (1,550.23) | (1,110.63) | (458.05) | (28.59) | (163.99) | (39.00) |
EV/EBIT |
40.65 | 59.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 |
Price to Operating Income |
22.08 | 40.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
5.93 | 5.22 | 4.56 | 3.60 | 3.15 | 1.92 | 3.57 | 1.49 | 0.00 |
Cash ROIC |
(2.22%) | 0.38% | (0.84%) | (0.89%) | 1.48% | 2.42% | 2.95% | 62.60% | (66.80%) |
Accounts Receivable Turnover |
1.95 | 2.09 | 2.10 | 2.25 | 2.29 | 2.25 | 3.13 | 1.81 | 0.00 |
Accounts Payable Turnover |
1.42 | 1.55 | 1.59 | 1.64 | 1.56 | 1.60 | 2.28 | 3.59 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
266.25 | 252.66 | 248.26 | 266.46 | 321.05 | 335.07 | 218.39 | 191.86 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
770.63 | 664.94 | 579.89 | 436.41 | 248.17 | 107.15 | 44.09 | 44.09 | — |
Average Payables |
742.79 | 667.13 | 572.55 | 438.55 | 255.86 | 108.92 | 42.58 | 14.40 | 14.40 |
Average Assets |
3,698.48 | 3,518.33 | 3,482.06 | 3,169.24 | 2,203.11 | 964.34 | 269.30 | 92.41 | 92.50 |
Average Common Equity |
1,046.11 | 1,013.42 | 1,079.02 | 1,163.42 | 978.58 | 503.56 | 87.25 | (51.38) | (52.00) |
Columns are period end dates